What it says
What this says
As at Fri 9 Oct 2026Unexecuted draft MSA dated 5 Mar 2026 for B-Viz Enterprise: availability 99.9%, P1 first response thirty minutes, annual recurring amount £119k after a 5% first-term discount. Total contract value £149k includes the one-off implementation.
What it is: a draft Master Services Agreement between BG-Demo and Quabbin Clinical Research, marked "DRAFT. Not yet executed. Subject to review by both parties." It has no effect until both parties sign.
Commits: Enterprise subscription from 7 Apr 2026 to 6 Apr 2027, billed quarterly, payable within 30 days. Availability 99.9%, P1 first response thirty minutes, nightly refresh complete by 07:00 customer local time on business days.
Unusual: a 5% discount on the first term only, applied to a £125k unit price. Service credits cover availability and data freshness at 10% of one month's fee per breach month.
Not settled: liability wording, the final connector list and each go-live commitment, and data residency are all open. Renewal price is only to be "confirmed by BG-Demo ahead of the end date". The text does not show that any executed copy exists, so the executed order form, not this draft, decides contracted terms.
As found in this document
As at Fri 9 Oct 2026- Date end6 Apr 2027Source: the AI read of this record
- Date start7 Apr 2026Source: the AI read of this record
- Price£118,750Source: the AI read of this record
- Availability99.9%Source: the AI read of this record
- Priority-one first responseThirty minutesSource: the AI read of this record
- Nightly refreshComplete by 07:00 customer local time on business daysSource: the AI read of this record
- Service credits10% of one month's fee for each month in which a breach occurs, for availability and data freshnessSource: the AI read of this record
- Annual recurring amount£118,750Source: the AI read of this record
- Total contract value£148,750, which includes the one-off implementation fee and is not an annual priceSource: the AI read of this record
- BillingThe subscription is billed quarterlySource: the AI read of this record
- Paymentpayable within 30 days of the invoice dateSource: the AI read of this record
The document
Body
Quabbin Clinical Research - Master Services Agreement v2
DRAFT. Not yet executed. Subject to review by both parties.
Draft date: 5 Mar 2026 Version: 2
Parties
- Supplier: BG-Demo, London
- Customer: Quabbin Clinical Research, Boston
BG-Demo account owner: Jordan Pike, Account Executive, US. Customer success lead: Hollie Grieve.
1. Services
1.1 BG-Demo will provide the B-Viz Enterprise subscription and the Enterprise implementation described in the order lines below.
1.2 B-Viz is built and run inside the Customer's own Snowflake account.
1.3 The implementation includes support for the Customer's security review and the set-up of up to twelve connectors.
2. Order lines
| SKU | Description | Qty | Unit price | Discount | Net |
|---|---|---|---|---|---|
| SUB-ENTERPRISE | B-Viz Enterprise subscription (annual, recurring) | 1 | £125k | 5% | £119k |
| IMP-ENTERPRISE | Implementation, Enterprise (twelve weeks, security review, up to twelve connectors; one-off) | 1 | £30k | 0% | £30k |
Annual recurring amount: £119k Total contract value: £149k, which includes the one-off implementation fee and is not an annual price.
Read the whole document (3,049 characters)
The discount applies to the first term only.
3. Term
3.1 The subscription starts on 7 Apr 2026 and ends on 6 Apr 2027.
3.2 Renewal terms, including the price at renewal, will be confirmed by BG-Demo ahead of the end date.
4. Billing and payment
4.1 The subscription is billed quarterly.
4.2 Invoices are issued in pounds sterling and are payable within 30 days of the invoice date.
4.3 The implementation fee is invoiced separately as a one-off charge.
5. Service levels
| Measure | Commitment |
|---|---|
| Availability | 99.9% |
| Priority-one first response | Thirty minutes |
| Nightly refresh | Complete by 07:00 customer local time on business days |
6. Service credits
6.1 Service credits are available for availability and for data freshness.
6.2 The credit is 10% of one month's fee for each month in which a breach occurs.
6.3 A system that answers on stale data counts as available. A freshness breach is assessed separately under this clause.
7. Data and security
7.1 The Customer's data remains in the Customer's Snowflake account.
7.2 BG-Demo will support the Customer's security review and will disclose any gap openly.
8. Open points in this draft
- The Customer's legal team has yet to confirm the liability wording.
- The final connector list and each go-live commitment are to be agreed before execution.
- Data residency arrangements are to be confirmed by the Customer.
9. Precedence
9.1 Once executed, the order form governs contracted price and terms. This draft has no effect until both parties have signed.
Signatures
| For BG-Demo | For Quabbin Clinical Research |
|---|---|
| Authorised signatory, BG-Demo | Authorised signatory, Quabbin Clinical Research |
| Signature: to be added on execution | Signature: to be added on execution |
| Date: on execution | Date: on execution |
Unusual terms
As at Fri 9 Oct 2026- 5% first-term discount
- Freshness service credit
- Draft with open liability, connector and residency points